Explore opportunities with Novartis below.
Montreal, November 15, 2024 – Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is extremely disappointed that negotiations for PLUVICTO™ (lutetium (177Lu) vipivotide tetraxetan injection), a ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Bien que je travaille pour Novartis depuis 13 ans, dont les quatre dernières années en Belgique, je pense souvent à l'époque où j'étais oncologue dans un hôpital au Portugal. Au cours de ces années, j ...
Hoewel ik al meer dan dertien jaar voor Novartis werk, waarvan de laatste vier jaar in België, denk ik nog vaak terug aan mijn periode als oncoloog in een ziekenhuis in Portugal. Als arts ondervond ik ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Zum 15. Mal: Novartis prämiert vielversprechende Forschungsprojekte in der Multiplen Sklerose (MS) mit insgesamt 100.000 Euro Dr. Sofia Meyer zu Reckendorf, Ulm, setzt sich in der Kategorie ,Präklinik ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
The Philippine Press Institute (PPI) held a health reporting workshop to help local journalists gain a deeper understanding of low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”) ...